
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Medullary sponge kidney
Introduction
Overview
Overview
Medullary sponge kidney is a congenital disorder of the kidneys characterized by a cystic dilatation of the collecting tubules in one or both kidneys.
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Historical Perspective
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Classification
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Pathophysiology
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Causes
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Differentiating Medullary sponge kidney from other Diseases
Overview
Medullary sponge kidney must be differentiated from other diseases that may cause renal cysts, such as Autosomal dominant and autosomal recessive polycystic kidney disease, simple renal cysts, tuberous sclerosis complex, von Hippel-Lindau disease.
Differentiating medullary sponge kidney from other Diseases
Medullary sponge kidney must be differentiated from other diseases that may cause renal cysts, such as Autosomal dominant and autosomal recessive polycystic kidney disease, simple renal cysts, tuberous sclerosis complex, von Hippel-Lindau disease.
| Diseases | Clinical manifestations | Paraβclinical findings | Gold standard | Additional findings | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Physical examination | |||||||||||
| Lab Findings | Imaging | Histopathology | ||||||||||
| Flank/abdominal pain | Polyuria | Hematuria | Hepatomegaly | Bilateral flank masses | Hypertension | Urinalysis | Ultrasound | CT scan | ||||
| Medullary sponge kidney[1][2] | + | +/β | + | β | + | β |
|
|
β |
| ||
| Autosomal dominant polycystic kidney disease (ADPKD)[3] | + | + | + | + | + | + |
|
|
Ultrasound | Extrarenal manifestations: | ||
| Autosomal recessive polycystic kidney disease (ARPKD)[4] | + | + | + | + | + | + |
|
|
Ultrasound | Extrarenal manifestations: | ||
| Simple renal cyst[5] | β | β | β | β | + | β | β |
|
β |
|
β |
|
| Tuberous sclerosis complex[6][7] | +/β | +/β | +/β | β | + | β | β |
|
|
β |
| |
| Von Hippel-Lindau disease[8][9] | + | +/β | + | β | + | β | β |
|
|
CT scan | ||
References
- β Gambaro G, Feltrin GP, Lupo A, Bonfante L, D’Angelo A, Antonello A (February 2006). “Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s”. Kidney Int. 69 (4): 663β70. doi:10.1038/sj.ki.5000035. PMIDΒ 16395272.
- β Levine E, Hartman DS, Meilstrup JW, Van Slyke MA, Edgar KA, Barth JC (August 1997). “Current concepts and controversies in imaging of renal cystic diseases”. Urol. Clin. North Am. 24 (3): 523β43. PMIDΒ 9275977.
- β Gabow PA (July 1993). “Autosomal dominant polycystic kidney disease”. N. Engl. J. Med. 329 (5): 332β42. doi:10.1056/NEJM199307293290508. PMIDΒ 8321262.
- β Adeva M, El-Youssef M, Rossetti S, Kamath PS, Kubly V, Consugar MB, Milliner DM, King BF, Torres VE, Harris PC (January 2006). “Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD)”. Medicine (Baltimore). 85 (1): 1β21. doi:10.1097/01.md.0000200165.90373.9a. PMIDΒ 16523049.
- β Ravine D, Gibson RN, Donlan J, Sheffield LJ (December 1993). “An ultrasound renal cyst prevalence survey: specificity data for inherited renal cystic diseases”. Am. J. Kidney Dis. 22 (6): 803β7. PMIDΒ 8250026.
- β Umeoka S, Koyama T, Miki Y, Akai M, Tsutsui K, Togashi K (2008). “Pictorial review of tuberous sclerosis in various organs”. Radiographics. 28 (7): e32. doi:10.1148/rg.e32. PMIDΒ 18772274.
- β Manoukian SB, Kowal DJ (May 2015). “Comprehensive imaging manifestations of tuberous sclerosis”. AJR Am J Roentgenol. 204 (5): 933β43. doi:10.2214/AJR.13.12235. PMIDΒ 25905927.
- β Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA (November 1990). “Clinical features and natural history of von Hippel-Lindau disease”. Q. J. Med. 77 (283): 1151β63. PMIDΒ 2274658.
- β Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (June 2003). “von Hippel-Lindau disease”. Lancet. 361 (9374): 2059β67. doi:10.1016/S0140-6736(03)13643-4. PMIDΒ 12814730.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Epidemiology and Demographics
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Overview
Epidemiolgoy and Demographics
It has been estimated to occur with a prevalence of between 1 in every 5,000-10,000 individuals in a population.
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Risk Factors
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Screening
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Natural History, Complications and Prognosis
Overview
Natural History,Complications and Prognosis
Complications such as infection, hematuria, and nephrolithiasis may be the presenting complaint in approximately 10% of patients.
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Diagnosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Β ; Associate Editor(s)-in-Chief: Cafer Zorkun M.D., PhD.
